Knight Therapeutics Inc - Significant Ownership

Signature - Title
Knight Therapeutics Inc. - Samira Sakhia/President and Chief Executive Officer
Location
Montreal, Quebec, Canada
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Knight Therapeutics Inc.

Significant Ownership of Knight Therapeutics Inc

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SNYR Synergy CHC Corp. Common Stock, par value $0.00001 per share 17.03% $5.1M 1.48M KNIGHT THERAPEUTICS INC. Dec 31, 2024

Schedules 13D/G Reported by Knight Therapeutics Inc:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.